Arax Advisory Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.65M | Buy |
25,026
+12,863
| +106% | +$2.39M | 0.21% | 86 |
|
2025
Q1 | $2.55M | Buy |
12,163
+2,018
| +20% | +$423K | 0.16% | 97 |
|
2024
Q4 | $1.8M | Buy |
10,145
+2,675
| +36% | +$475K | 0.11% | 112 |
|
2024
Q3 | $1.48M | Buy |
7,470
+490
| +7% | +$96.8K | 0.13% | 88 |
|
2024
Q2 | $1.2M | Buy |
6,980
+1,172
| +20% | +$201K | 0.12% | 104 |
|
2024
Q1 | $1.06M | Sell |
5,808
-2,343
| -29% | -$427K | 0.11% | 103 |
|
2023
Q4 | $1.26M | Sell |
8,151
-395
| -5% | -$61.2K | 0.14% | 80 |
|
2023
Q3 | $1.27M | Buy |
8,546
+2,378
| +39% | +$354K | 0.16% | 73 |
|
2023
Q2 | $831K | Buy |
6,168
+121
| +2% | +$16.3K | 0.11% | 90 |
|
2023
Q1 | $964K | Buy |
6,047
+221
| +4% | +$35.2K | 0.13% | 78 |
|
2022
Q4 | $942K | Sell |
5,826
-377
| -6% | -$60.9K | 0.13% | 80 |
|
2022
Q3 | $832K | Buy |
6,203
+250
| +4% | +$33.5K | 0.13% | 75 |
|
2022
Q2 | $912K | Sell |
5,953
-360
| -6% | -$55.2K | 0.14% | 75 |
|
2022
Q1 | $1.02M | Buy |
6,313
+6
| +0.1% | +$972 | 0.14% | 76 |
|
2021
Q4 | $854K | Buy |
6,307
+134
| +2% | +$18.1K | 0.11% | 79 |
|
2021
Q3 | $666K | Buy |
6,173
+275
| +5% | +$29.7K | 0.09% | 87 |
|
2021
Q2 | $664K | Buy |
+5,898
| New | +$664K | 0.09% | 84 |
|
2020
Q4 | $489K | Buy |
4,565
+114
| +3% | +$12.2K | 0.07% | 90 |
|
2020
Q3 | $390K | Buy |
4,451
+73
| +2% | +$6.4K | 0.07% | 101 |
|
2020
Q2 | $430K | Sell |
4,378
-124
| -3% | -$12.2K | 0.08% | 88 |
|
2020
Q1 | $343K | Sell |
4,502
-58
| -1% | -$4.42K | 0.08% | 91 |
|
2019
Q4 | $404K | Buy |
4,560
+2,705
| +146% | +$240K | 0.12% | 79 |
|
2019
Q3 | $140K | Buy |
1,855
+2
| +0.1% | +$151 | 0.04% | 197 |
|
2019
Q2 | $135K | Buy |
+1,853
| New | +$135K | 0.04% | 188 |
|
2018
Q4 | $176K | Sell |
1,914
-64
| -3% | -$5.89K | 0.07% | 137 |
|
2018
Q3 | $187K | Buy |
+1,978
| New | +$187K | 0.08% | 125 |
|